175 related articles for article (PubMed ID: 35870998)
1. Human liver microsomes study on the inhibitory effect of plantainoside D on the activity of cytochrome P450 activity.
Zhou J; Qian X; Zhou Y; Xiong S; Ji S; Wang Y; Zhao P
BMC Complement Med Ther; 2022 Jul; 22(1):197. PubMed ID: 35870998
[TBL] [Abstract][Full Text] [Related]
2.
Zhang N; Liu J; Chen Z; Dou W
Pharm Biol; 2019 Dec; 57(1):571-576. PubMed ID: 31456483
[No Abstract] [Full Text] [Related]
3. Screening of 16 major drug glucuronides for time-dependent inhibition of nine drug-metabolizing CYP enzymes - detailed studies on CYP3A inhibitors.
Kahma H; Paludetto MN; Neuvonen M; Kurkela M; Filppula AM; Niemi M; Backman JT
Eur J Pharm Sci; 2024 Jul; 198():106735. PubMed ID: 38423227
[TBL] [Abstract][Full Text] [Related]
4. Effect of tubeimoside I on the activity of cytochrome P450 enzymes in human liver microsomes.
Wang R; Zheng K; Liu Y; Ji S; Tang Y; Wang J; Jiang R
Xenobiotica; 2024 Feb; 54(2):57-63. PubMed ID: 38166553
[TBL] [Abstract][Full Text] [Related]
5. Flavokawain A inhibits Cytochrome P450 in in vitro metabolic and inhibitory investigations.
Niu L; Ding L; Lu C; Zuo F; Yao K; Xu S; Li W; Yang D; Xu X
J Ethnopharmacol; 2016 Sep; 191():350-359. PubMed ID: 27318274
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of inhibitory effects of caffeic acid and quercetin on human liver cytochrome p450 activities.
Rastogi H; Jana S
Phytother Res; 2014 Dec; 28(12):1873-8. PubMed ID: 25196644
[TBL] [Abstract][Full Text] [Related]
7. In vitro inhibitory effects of pristimerin on human liver cytochrome P450 enzymes.
Hao X; Yuan J; Xu Y; Wang Z; Hou J; Hu T
Xenobiotica; 2018 Dec; 48(12):1185-1191. PubMed ID: 28385095
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of the main metabolites of Apatinib on CYP450 isozymes in human and rat liver microsomes.
Pang NH; Xu RA; Chen LG; Chen Z; Hu GX; Zhang BW
Toxicol In Vitro; 2024 Mar; 95():105739. PubMed ID: 38042355
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of sanguinarine on human liver cytochrome P450 enzymes.
Qi XY; Liang SC; Ge GB; Liu Y; Dong PP; Zhang JW; Wang AX; Hou J; Zhu LL; Yang L; Tu CX
Food Chem Toxicol; 2013 Jun; 56():392-7. PubMed ID: 23500771
[TBL] [Abstract][Full Text] [Related]
10. Physcion inhibition of CYP2C9, 2D6 and 3A4 in human liver microsomes.
Liu L; Sun S; Li X
Pharm Biol; 2024 Dec; 62(1):207-213. PubMed ID: 38353248
[TBL] [Abstract][Full Text] [Related]
11. In vitro inhibition of human cytochrome P450 enzymes by the novel atypical antipsychotic drug asenapine: a prediction of possible drug-drug interactions.
Wójcikowski J; Danek PJ; Basińska-Ziobroń A; Pukło R; Daniel WA
Pharmacol Rep; 2020 Jun; 72(3):612-621. PubMed ID: 32219694
[TBL] [Abstract][Full Text] [Related]
12. Metabolic interactions of magnolol with cytochrome P450 enzymes: uncompetitive inhibition of CYP1A and competitive inhibition of CYP2C.
Kim SB; Kang HE; Cho HJ; Kim YS; Chung SJ; Yoon IS; Kim DD
Drug Dev Ind Pharm; 2016; 42(2):263-9. PubMed ID: 26133083
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibitory effects of suberosin on CYP1A2 in human liver microsomes.
Paudel S; Jo H; Lee T; Lee S
Biopharm Drug Dispos; 2023 Oct; 44(5):365-371. PubMed ID: 37448189
[TBL] [Abstract][Full Text] [Related]
14.
Zhang C; Li Y; Yin C; Zheng J; Liu G
Pharm Biol; 2021 Dec; 59(1):935-940. PubMed ID: 35294326
[TBL] [Abstract][Full Text] [Related]
15. 4-O-galloylalbiflorin inhibits the activity of CYP3A, 2C9, and 2D in human liver microsomes.
Sun Y; He M; Sun Y; Wei J
Xenobiotica; 2021 Aug; 51(8):871-876. PubMed ID: 34082641
[TBL] [Abstract][Full Text] [Related]
16.
Li M; Liu X; Wang Y; Ju X
Xenobiotica; 2020 Oct; 50(10):1202-1207. PubMed ID: 32338127
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Inhibition of Human CYP450s 1A2, 2C9, 3A4/5, 2D6 and 2E1 by Grandisin.
Habenschus MD; Moreira FL; Lopes NP; de Oliveira ARM
Planta Med; 2017 May; 83(8):727-736. PubMed ID: 28073119
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Predictions of Cytochrome P450 (P450)-Mediated In Vivo Cannabinoid-Drug Interactions Based on Reversible and Time-Dependent P450 Inhibition in Human Liver Microsomes.
Bansal S; Paine MF; Unadkat JD
Drug Metab Dispos; 2022 Apr; 50(4):351-360. PubMed ID: 35115300
[TBL] [Abstract][Full Text] [Related]
19.
Zhao H; Xue S; Meng Q; Zhou C
Xenobiotica; 2021 Sep; 51(9):977-982. PubMed ID: 34176447
[TBL] [Abstract][Full Text] [Related]
20. In vitro inhibitory effect of obtusofolin on the activity of CYP3A4, 2C9, and 2E1.
Liu N; Chen P; Du X; Sun J; Han S
BMC Complement Med Ther; 2021 Sep; 21(1):218. PubMed ID: 34470620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
